SCIENTURE HOLDINGS, INC. Proceeds from Collection of Notes Receivable
SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from Collection of Notes Receivable of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2015-11-02
- SCIENTURE HOLDINGS, INC. proceeds from collection of notes receivable for the quarter ending 2015-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. proceeds from collection of notes receivable for the quarter ending 2014-09-30 was $0.00.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-07-30 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $160.00K 10-Q · filed 2015-11-02 | |
| 2014-06-30 | $160.00K 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |